Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acknowledged, adequatein, andin, andRevenue, argued, asIn, Avion, Balcoltra, bearing, bill, captioned, captionedPeng, cast, Clark, codification, concurrent, content, convergence, cut, Deferral, deleted, Deposit, dismissed, Distinguishing, Division, dual, Dysmenorrhoea, dysplasia, explanatory, forgo, hinder, Hoyt, identification, internet, jointly, judge, Lastly, Lichtenthal, Mandatorily, moral, Natazia, noncash, Noncontrolling, Nonpublic, objectionable, outlay, PCAOB, Peng, prejudice, provisional, Reauthorization, refinement, reiterated, resume, resumption, shore, sincerely, streamlined, Taxation, thein, Topic, unaffiliated, unscheduled, unspecified, upcoming, Yasmin
Removed:
accomplish, accredited, Alesse, attributed, bridge, cGMP, clause, compounding, consistently, conversion, dated, deducting, entirety, FDIC, fell, gathering, Gianvi, liquidation, Lo, Mirena, Molecular, NOL, par, presently, reclassifying, retained, revealing, Secretary, silky, subordinate, subordinated, vii, virtue
Filing tables
Filing exhibits
Related press release
AGXRW similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements:
- (1)
- Registration Statement (Form S-8 No. 333-199441), pertaining to the Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,
- (2)
- Registration Statement (Form S-3 No. 333-205120) of Agile Therapeutics, Inc., and
- (3)
- Registration Statement (Form S-8 No. 333-205116), pertaining to Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,
- (4)
- Registration Statement (Form S-8 No. 333-217807), pertaining to Agile Therapeutics, Inc. 2014 Incentive Compensation Plan (filed on May 9, 2017)
of our report dated March 12, 2018, with respect to the financial statements of Agile Therapeutics, Inc., included in this Annual Report (Form 10-K) of Agile Therapeutics, Inc. for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Iselin, New Jersey
March 12, 2018
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM